Unknown

Dataset Information

0

Oligomerization Alters Binding Affinity Between Amyloid Beta and a Modulator of Peptide Aggregation.


ABSTRACT: The soluble oligomeric form of the amyloid beta (A?) peptide is the major causative agent in the molecular pathogenesis of Alzheimer's disease (AD). We have previously developed a pyrroline-nitroxyl fluorene compound (SLF) that blocks the toxicity of A?. Here we introduce the multi-parametric surface plasmon resonance (MP-SPR) approach to quantify SLF binding and effect on the self-association of the peptide via a label-free, real-time approach. Kinetic analysis of SLF binding to A? and measurements of layer thickness alterations inform on the mechanism underlying the ability of SLF to inhibit A? toxicity and its progression towards larger oligomeric assemblies. Depending on the oligomeric state of A?, distinct binding affinities for SLF are revealed. The A? monomer and dimer uniquely possess sub-nanomolar affinity for SLF via a non-specific mode of binding. SLF binding is weaker in oligomeric A?, which displays an affinity for SLF on the order of 100 ?M. To complement these experiments we carried out molecular docking and molecular dynamics simulations to explore how SLF interacts with the A? peptide. The MP-SPR results together with in silico modeling provide affinity data for the SLF-A? interaction and allow us to develop a new general method for examining protein aggregation.

SUBMITTER: Hilt S 

PROVIDER: S-EPMC6130836 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Oligomerization Alters Binding Affinity Between Amyloid Beta and a Modulator of Peptide Aggregation.

Hilt Silvia S   Rojalin Tatu T   Viitala Tapani T   Koivuniemi Artturi A   Bunker Alex A   Hogiu Sebastian Wachsmann SW   Kálai Tamás T   Hideg Kálmán K   Yliperttula Marjo M   Voss John C JC  

The journal of physical chemistry. C, Nanomaterials and interfaces 20171010 43


The soluble oligomeric form of the amyloid beta (Aβ) peptide is the major causative agent in the molecular pathogenesis of Alzheimer's disease (AD). We have previously developed a pyrroline-nitroxyl fluorene compound (SLF) that blocks the toxicity of Aβ. Here we introduce the multi-parametric surface plasmon resonance (MP-SPR) approach to quantify SLF binding and effect on the self-association of the peptide via a label-free, real-time approach. Kinetic analysis of SLF binding to Aβ and measurem  ...[more]

Similar Datasets

| S-EPMC3102090 | biostudies-literature
| S-EPMC3369720 | biostudies-literature
| S-EPMC4888463 | biostudies-literature
| S-EPMC6445117 | biostudies-literature
| S-EPMC4196732 | biostudies-literature
| S-EPMC2547438 | biostudies-literature
| S-EPMC3756451 | biostudies-literature
| S-EPMC8123703 | biostudies-literature
| S-EPMC3003082 | biostudies-literature
| S-EPMC7059649 | biostudies-literature